Explore Ruxolitinib Phosphate, a high-purity pharmaceutical intermediate and potent JAK inhibitor. Learn about its critical role in treating myeloproliferative disorders like myelofibrosis and polycythemia vera, and its emerging use in anti-tumor research.
